The American Journal of Medicine
Volume 123, Issue 1 , Page 3 , January 2010

Statins to Prevent Venous Thromboembolism in Patients with Cancer?

References 

  1. Grady D, Wenger NK, Herrington D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. Ann Intern Med. 2000;132:689–696
  2. Ray JG, Mamdani M, Tsuyuki RT, et al. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med. 2001;161:1405–1410
  3. Sorenson HT, Horvath-Puho E, Sogaard KK, et al. Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost. 2009;7:521–528
  4. Glynn RJ, Danielson E, Fonseca FAH, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 2009;360:1851–1861
  5. Kearney D, Fitzgerald D. The anti-thrombotic effects of statins. J Am Coll Cardiol. 1999;33:1305–1307
  6. Khemasuwan D, DiVietro ML, Tangdhanakanond K, et al. Statins decrease the occurrence of venous thromboembolism in patients with cancer. Am J Med. 2010;123:60–65

PII: S0002-9343(09)00708-6

doi: 10.1016/j.amjmed.2009.07.013

The American Journal of Medicine
Volume 123, Issue 1 , Page 3 , January 2010

Article Tools